Marché des systèmes de photobiostimulation médicale – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00022884
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 156
Buy Now

Le marché des systèmes de photobiostimulation médicale devrait atteindre 314,88 millions de dollars US d'ici 2028 contre 204,66 millions de dollars US en 2021 ; il devrait croître à un TCAC de 6,3 % de 2021 à 2028. Le nombre croissant de patients souffrant de troubles chroniques et de douleurs chroniques et la demande croissante de dispositifs de photobiostimulation pour la gestion de la douleur et le soin des plaies en raison de l'augmentation de la population gériatrique sont les principaux facteurs contribuant à la croissance du marché. Cependant, un cadre réglementaire strict limite la croissance du marché. La thérapie médicale de photobiostimulation est également connue sous le nom de luminothérapie de bas niveau (LLLT) et est utilisée pour réduire la douleur, l'inflammation et favoriser la cicatrisation des plaies. Les appareils de photobiostimulation modernes utilisent des longueurs d'onde spécifiques pour obtenir des résultats spécifiques. Les dispositifs de photobiostimulation fonctionnent principalement parce que la lumière agit sur une protéine dans les mitochondries de la cellule, ce qui entraîne une augmentation de l'ATP et une réduction du stress oxydatif. Une cascade de processus intracellulaires entraîne une amélioration des tissus et une réduction de l'inflammation.

Les pays de l'APAC connaissent une augmentation des cas de COVID-19. La baisse des visites en hospitalisation et en ambulatoire des chaînes d'hôpitaux privés est significative. Pour soulager les systèmes de santé, de nombreuses cliniques ont reporté les visites à l'hôpital. Ces événements sont susceptibles d'avoir un impact négatif sur le marché des dispositifs de surveillance de l'arythmie en Asie-Pacifique. Les segments de l'industrie médicale, y compris les appareils de photobiostimulation médicale, ont subi des pertes pendant la pandémie de COVID-19 en raison de la restriction des installations de fabrication et de la chaîne d'approvisionnement.



Régions lucratives pour le marché des systèmes de photobiostimulation médicale



Aperçu du marché



Le nombre croissant de patients souffrant de troubles chroniques et de douleurs chroniques alimente la croissance du marché des systèmes de photobiostimulation médicale



La douleur chronique peut être développée par une blessure ou une intervention chirurgicale. En outre, les maladies chroniques, telles que le cancer, les troubles musculo-squelettiques, les troubles rénaux, le diabète, l'obésité, la polyarthrite rhumatoïde (PR), l'endométriose, les migraines et la maladie d'Alzheimer (MA) sont parmi les principales causes de douleur chronique. La plupart des personnes âgées (> 60 %) souffrent de deux maladies chroniques ou plus. Selon les Centers for Disease Control and Prevention (CDC), en 2020, près de 6 personnes sur 10 aux États-Unis souffraient d'au moins une maladie chronique, et 4 personnes sur 10 souffraient de deux maladies chroniques ou plus. Le nombre de patients souffrant de troubles musculo-squelettiques est en hausse. Par exemple, selon les détails fournis par l'Organisation mondiale de la santé (OMS) en février 2021, environ 1,71 milliard de personnes dans le monde souffrent de troubles musculo-squelettiques. L'OMS déclare également que parmi ces troubles, la lombalgie est la charge la plus lourde pour le système de santé avec une prévalence de 568 millions de personnes dans le monde. Les maladies musculo-squelettiques sont la principale cause d'invalidité; en particulier, la lombalgie est une cause majeure d'invalidité dans 160 pays. En outre, le nombre de patients souffrant de douleur chronique est en augmentation. Selon l'enquête nationale sur la santé (NHIS) de 2019, la prévalence de la douleur chronique chez les adultes américains était de 20,4 %, la douleur chronique à fort impact représentant 7,4 %. La douleur chronique était la plus élevée chez les personnes âgées de 65 ans et plus (30,8 %), les adultes blancs non hispaniques (23,6 %) et les femmes (21,7 %). La douleur chronique à fort impact était la plus élevée chez les personnes âgées de 65 ans et plus (11,8 %) et les femmes (8,5 %). Les systèmes médicaux de photobiostimulation sont utilisés pour réduire la douleur, l'inflammation et l'œdème, favoriser la cicatrisation des plaies, des tissus plus profonds et des nerfs, et prévenir les lésions tissulaires. Par conséquent, le nombre croissant de patients souffrant de douleurs chroniques et d'autres maladies chroniques est le moteur de la croissance du marché des systèmes de photobiostimulation médicale. On estime que le segment de la lumière infrarouge détient la plus grande part du marché en 2021 et devrait croître au TCAC le plus élevé de 2021 à 2028. La thérapie infrarouge est une méthode innovante pour traiter la douleur et l'inflammation et est largement utilisée en médecine, en dentisterie, en médecine vétérinaire et dans les maladies auto-immunes. La thérapie infrarouge a été utilisée dans diverses applications pour aider les patients souffrant de douleurs ou de blessures, y compris la médecine sportive et les blessures musculo-squelettiques.

Marché des systèmes de photobiostimulation médicale, par produit - 2021 et 2028



< h3>Informations basées sur les applications

Basé sur l'application, le marché des systèmes de photobiostimulation médicale est segmenté en gestion de la douleur, soins des plaies, applications cosmétiques, autres. La gestion de la douleur est en outre segmentée en dentisterie, vétérinaire et autres. En 2021, le segment de la gestion de la douleur devrait détenir la plus grande part du marché. cela peut être attribué au vieillissement de la population et à l'augmentation de l'incidence des cas d'ostéoporose et d'arthrite dans le monde. Cependant, le segment des soins des plaies devrait croître au rythme le plus rapide au cours des prochaines années. Perspectives stratégiques Les entreprises opérant sur le marché des systèmes de photobiostimulation médicale mettent l'accent sur l'adoption de la stratégie d'innovations de produits pour répondre à l'évolution des demandes des clients à travers le monde, ce qui leur permet également de maintenir leur nom de marque sur le marché mondial.Marché des systèmes de photobiostimulation médicale - par produit
  • Lumière infrarouge

  • Lumière rouge

  • Lumière rouge


Photobiostimulation médicale Marché des systèmes - par application
  • Gestion de la douleur

  • Soin des plaies

  • Applications cosmétiques

  • Autres


Système médical de photobiostimulation Marché - par géographie
  • Amérique du Nord
    • États-Unis

    • Canada

    • Mexique



  • Europe
    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne

    • Reste de l'Europe



  • Asie-Pacifique (APAC)
    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • Reste de l'APAC



  • Moyen-Orient et Afrique (MEA)
    • Afrique du Sud

    • Arabie saoudite

    • EAU

    • Reste de la MEA



  • Amérique du Sud et centrale (SCAM) < ul>
  • Brésil

  • Argentine

  • Reste de SCAM




Profils des entreprises
  • BioLight Technologies LLC.

  • Omega Laser Systems Ltd

  • Vielight Inc.

  • Theradome Inc.

  • Lexington Intl., LLC

  • < li>THOR Photomedicine Ltd
  • Ingeneus

  • Système de croissance des cheveux iRestore

  • Meditech International Inc. (BIOFLEX Laser Therapy)

  • Apira Science, Inc. (iGrow Laser)


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is medical photobiostimulation system devices?

Medical photobiostimulation therapy is also known as low-level light therapy (LLLT) and is used to reduce pain, inflammation, and promote the healing of wounds. The photobiostimulation devices work on the principal because light works on a protein in the cell's mitochondria, which results in increased ATP and reduced oxidative stress. A cascade of intracellular processes results in improved tissue and reduced inflammation.

What are the driving factors for the medical photobiostimulation system devices market across the globe?

The factors that are driving growth of the market are growing number of patients suffering from chronic disorders and chronic pain and rising demand for photobiostimulation devices for pain management and wound care due to increasing geriatric population boost the market growth. However, stringent regulatory framework hampers the market growth.

Who are the major players in the medical photobiostimulation system devices market?

The Medical Photobiostimulation System Devices market majorly consists of the players such as Abbott, Koninklijke Philips N.V., General Electric Company, Hill-Rom Holding Inc., Medtronic, Biotronik, Inc., AliveCor, Inc, ACS Diagnostics, Medicalgorithmics, and OSI Systems, Inc amongst others.

Which country is dominated the medical photobiostimulation system devices market?

The medical photobiostimulation system market in the United States is expected to be the largest and fastest-growing market. The US is among the highly advanced countries having various technologies available for a robust medical infrastructure, and it is globally known for its involvement in the research and development pertaining to innovative treatment methods.

Which segment is dominating the medical photobiostimulation system devices market?

The global medical photobiostimulation system market based on product is segmented into infrared light, red light, and others. The Infrared light segment is estimated to account for the largest market share in the global medical photobiostimulation system market. The growth of the segment is attributed to increasing adoption in pain management such as arthritis, osteoporosis, and rising geriatric population.

Which region is the fastest growing the medical photobiostimulation system devices market?

Asia Pacific is expected to be the fastest growing region in the medical photobiostimulation system devices market. The growth of the medical photobiostimulation system market in this region is primarily due to rising geriatric population, and the growing government initiatives for awareness regarding pain management therapies. In addition, growing healthcare expenditure is likely to increase the growth opportunities during the coming years.

The List of Companies - Medical Photobiostimulation System Market

  1. BioLight Technologies LLC.
  2. Omega Laser Systems Ltd
  3. Vielight Inc.
  4. Theradome Inc.
  5. Lexington Intl., LLC
  6. THOR Photomedicine Ltd
  7. Ingeneus
  8. iRestore Hair Growth System
  9. Meditech International Inc. (BIOFLEX Laser Therapy)
  10. Apira Science, Inc. (iGrow Laser)

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports